New research suggests GLP-1 medications may inadvertently dampen romantic desire by altering brain regions associated with reward and addiction. This unexpected side effect has significant implications for health tech, pharmaceuticals, and even...
Explore the unexpected side effect of GLP-1 drugs on romantic desire and its impact on the health tech and pharmaceutical industries.
New data reveals a significant shift in enterprise AI spending, with Anthropic capturing the lion's share. This signals a new competitive dynamic.
Ramp data shows Anthropic now accounts for 73% of new enterprise AI spending, challenging OpenAI's market dominance.
The cost of capital is now the critical choke point, testing illiquid private debt and forcing enterprises to reassess financing assumptions. Geopolitical events are delaying Fed rate cuts, and AI valuations face increased scrutiny.
Private credit faces a stress test as the US 10-year Treasury yield nears 5%, driven by rising rates and geopolitical tensions. Learn how this impacts financing and valuations.
Private credit is signaling a correction in SaaS loans, driven by AI's impact and asset-liability mismatches. This isn't 2008, but investors are hedging and stress-testing exposures as valuations fall.
Private credit markets show signs of a major correction in SaaS loans due to AI disruption and asset-liability mismatches. Learn what it means for your portfolio.
